Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xandra O Breakefield

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay Saydam
Human Gene Therapy|March 28, 2002
Critical issues in gene therapy for neurologic diseaseGary Hsich, Miguel Sena-Esteves, Xandra O Breakefield
Methods in Molecular Medicine|January 16, 2003
Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNAYoshinaga Saeki, Xandra O Breakefield, E Antonio Chiocca
Human Molecular Genetics|March 25, 2011
Genetic therapy for the nervous systemWilliam J Bowers, Xandra O Breakefield, Miguel Sena-Esteves
Trends in Molecular Medicine|April 8, 2014
Extracellular vesicles: emerging targets for cancer therapyPieter Vader, Xandra O Breakefield, Matthew J A Wood
Advances in Neurology|September 27, 2003
TorsinA and early-onset torsion dystoniaD Cristopher Bragg, Damien J Slater, Xandra O Breakefield
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
Noninvasive in vivo monitoring of extracellular vesiclesCharles P Lai, Bakhos A Tannous, Xandra O Breakefield
Methods (San Diego, Calif.)|May 4, 2004
Targeting HSV amplicon vectorsPaola Grandi, Matthew Spear, Xandra O Breakefield, et al.
Pain|September 1, 1996
Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type IIGudarz Davar, Christo Shalish, Anat Blumenfeld, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2011
Gesicles: Microvesicle "cookies" for transient information transfer between cellsXandra O Breakefield, Robert M Frederickson, Richard J Simpson
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay Saydam
Human Gene Therapy|March 28, 2002
Critical issues in gene therapy for neurologic diseaseGary Hsich, Miguel Sena-Esteves, Xandra O Breakefield
Methods in Molecular Medicine|January 16, 2003
Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNAYoshinaga Saeki, Xandra O Breakefield, E Antonio Chiocca
Human Molecular Genetics|March 25, 2011
Genetic therapy for the nervous systemWilliam J Bowers, Xandra O Breakefield, Miguel Sena-Esteves
Trends in Molecular Medicine|April 8, 2014
Extracellular vesicles: emerging targets for cancer therapyPieter Vader, Xandra O Breakefield, Matthew J A Wood
Advances in Neurology|September 27, 2003
TorsinA and early-onset torsion dystoniaD Cristopher Bragg, Damien J Slater, Xandra O Breakefield
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
Noninvasive in vivo monitoring of extracellular vesiclesCharles P Lai, Bakhos A Tannous, Xandra O Breakefield
Methods (San Diego, Calif.)|May 4, 2004
Targeting HSV amplicon vectorsPaola Grandi, Matthew Spear, Xandra O Breakefield, et al.
Pain|September 1, 1996
Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type IIGudarz Davar, Christo Shalish, Anat Blumenfeld, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2011
Gesicles: Microvesicle "cookies" for transient information transfer between cellsXandra O Breakefield, Robert M Frederickson, Richard J Simpson
Pageof 21